Otamixaban formulations with improved stability
AssigneeSanofi
InventorsWalter KAMM, Till Bussemer, Doris Andert, Bernd Kühn, Ernst-Josef Todt
Life of this patent
Estimating the term…
Loading patent…
AssigneeSanofi
InventorsWalter KAMM, Till Bussemer, Doris Andert, Bernd Kühn, Ernst-Josef Todt
Estimating the term…
The invention relates to a pharmaceutical composition comprising methyl (2R,3R)-2-{3-[amino(imino)methyl]benzyl}-3-{[4-(1-oxidopyridin-4-yl)benzoyl]amino}butanoate or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable acidic reacting compound or to an aqueous solution or dispersion of the composition as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from conditions which can be ameliorated by the administration of an inhibitor of Factor Xa.
An aqueous pharmaceutical composition for injection comprising
Dependencies are inferred from the claim text.